Forward Pharma A/S
FWPAY · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $49 | $56 | $51 | $43 |
| - Cash | $71 | $79 | $78 | $83 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$22 | -$23 | -$26 | -$39 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$6 | -$0 | -$6 | -$15 |
| % Margin | – | – | – | – |
| Net Income | -$2 | -$6 | -$4 | -$9 |
| % Margin | – | – | – | – |
| EPS Diluted | -77.41 | -268.72 | -177.58 | -368.51 |
| % Growth | 71.2% | -51.3% | 51.8% | – |
| Operating Cash Flow | -$2 | -$6 | -$2 | -$15 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$2 | -$6 | -$2 | -$15 |